Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Change in Acquisitions & Divestments (2018 - 2025)

UroGen Pharma's Change in Acquisitions & Divestments history spans 8 years, with the latest figure at $28.3 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 59.59% year-over-year to $28.3 million; the TTM value through Dec 2025 reached $139.2 million, up 29.29%, while the annual FY2025 figure was $139.2 million, 29.29% up from the prior year.
  • Change in Acquisitions & Divestments reached $28.3 million in Q4 2025 per URGN's latest filing, down from $40.2 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $70.0 million in Q4 2024 to a low of -$42.2 million in Q4 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $18.1 million, with a median of $14.5 million recorded in 2021.
  • Peak YoY movement for Change in Acquisitions & Divestments: plummeted 100.8% in 2022, then skyrocketed 4344.32% in 2023.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at -$42.2 million in 2021, then surged by 154.84% to $23.1 million in 2022, then plummeted by 84.71% to $3.5 million in 2023, then soared by 1879.21% to $70.0 million in 2024, then crashed by 59.59% to $28.3 million in 2025.
  • Per Business Quant, the three most recent readings for URGN's Change in Acquisitions & Divestments are $28.3 million (Q4 2025), $40.2 million (Q3 2025), and $30.3 million (Q2 2025).